Silibinin down-regulates expression of secreted phospholipase A2 enzymes in cancer cells.

Abstract

Silibinin exhibits inhibitory effects on basal and cytokine-induced expression of sPLA2s in cancer cells and therefore, may have the potential to protect against up-regulation of hGIIA and other sPLA2 isoforms during inflammation and cancer.